Last edition
News about "Novel AAV Capsids"
Biogen and Capsigen announced that they have entered into a strategic research collaboration, Capsigen's proprietary TRADE platform and associated technologies will be utilized with the aim to create and identify novel AAV capsids tailored to meet disease-specific transduction profiles.
Novel AAV Capsids | 12/05/2021 | By Hemant | 384
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members